COVID-19 Breakthrough Infection Among Vaccinated Population in the United Arab Emirates.

Dash, Nihar Ranjan; Barqawi, Hiba Jawdat; Obaideen, Anas A; Al Chame, Hanae Qousae; Samara, Kamel A; Qadri, Rama; Eldesouki, Salma

Dash, Nihar Ranjan; Barqawi, Hiba Jawdat; Obaideen, Anas A; Al Chame, Hanae Qousae; Samara, Kamel A; Qadri, Rama; Eldesouki, Salma.

Afiliação

Dash NR; Clinical Sciences Department, College of Medicine, University of Sharjah, 27272, Sharjah, United Arab Emirates. ndash@sharjah.ac.ae.
Barqawi HJ; Clinical Sciences Department, College of Medicine, University of Sharjah, 27272, Sharjah, United Arab Emirates.
Obaideen AA; College of Medicine, University of Sharjah, Sharjah, United Arab Emirates.
Al Chame HQ; College of Medicine, University of Sharjah, Sharjah, United Arab Emirates.
Samara KA; College of Medicine, University of Sharjah, Sharjah, United Arab Emirates.
Qadri R; College of Medicine, University of Sharjah, Sharjah, United Arab Emirates.
Eldesouki S; College of Medicine, University of Sharjah, Sharjah, United Arab Emirates.

J Epidemiol Glob Health ; 13(1): 67-90, 2023 03.

Article em En | MEDLINE | ID: mdl-36795274

Assuntos

COVID-19; Adulto Jovem; Humanos; Masculino; Emirados Árabes Unidos; Vacinas contra COVID-19; Infecções Irruptivas; Estudos Transversais

Palavras-chave

Breakthrough infections; COVID-19; Covid vaccine; Pfizer-BioNTech; Sinopharm BBIBP-CorV; UAE

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans / Male País/Região como assunto: Asia Idioma: En Revista: J Epidemiol Glob Health Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Emirados Árabes Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google